CD44 and neoplasm: We demonstrated that TGIF1 inactivation promotes KrasG12D-driven pancreatic tumorigenesis and that TGIF1 ablation has tumor-promoting effects and activates the HAS2/CD44 cancer stemness pathway, a potent regulator in the induction of TAM polarization, which enhances PDAC distant metastasis.